ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 985

IL-6 and TNF-a Cooperate to Modulate Cell Cycle of RA-FLS Via Cyclin Dependent Kinase 6

Kenta Kaneshiro1, Kohsuke Yoshida1, Koto Uchida1, Alisa Yaekura1, Ikumi Okumura1, Koji Tateishi2, Yasuhiro Terashima2, Nao Shibanuma3, Yoshitada Sakai4 and Akira Hashiramoto1, 1Department of Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan, 2Dept. of Orthopaedic Surgery, Konan Kakogawa Hospital, Kakogawa, Japan, 3Departmant of Orthopaedic Surgery, Kobe Kaisei Hospital, Kobe, Japan, 4Division of Rehabilitation Medicine, Kobe University Graduate School of Medicine, Kobe, Japan

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: cytokines, rheumatoid arthritis (RA) and synovial cells, synovial fluid

Session Information

Date: Monday, October 22, 2018

Title: Cytokines and Cell Trafficking Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid Arthritis (RA) is a chronic inflammatory disease characterized by a tumor-like synovial overgrowth leading to joint destructions.

IL-6 and TNF-a play an important role in the pathogenesis of RA, and the proliferation of RA-synoviocytes (FLS) is controlled by cell cycle regulators including Cyclins, Cyclin dependent kinases (CDK), CDK inhibitors (CKDIs) and retinoblastoma protein (RB).

To reveal actions of proinflammatory cytokines on the cell cycle of RA-FLS, we examined the expressions of the cell cycle regulators and the cellular viability under stimulations of IL-6 and TNF-a.

Methods:

RA-FLS were treated with or without IL-6/soluble IL-6 receptor (sIL-6R) (100ng/ml) or TNF-a (10ng/ml). The expressions of CDK4/6 CDKIs (p16INK4a, p21Cip1, p27Kip1) and Cyclin E1/2 mRNA were measured by Real-time PCR, the protein expression of CYCLIN D, CYCLIN E, RB and the phosphorylation of RB were measured by Western blot, the expression of CYCLIN D and the phosphorylation of RB were observed by immunofluorescence, and the cellular viabilities were measured by WST-8 and BrdU assay. In addition, siRNA/CDK6 was introduced into RA-FLS to measure the cellular viabilities, under stimulations with or without IL-6/sIL-6R or TNF-a.

Results:

IL-6/sIL-6R decreased the mRNA expression of p16INK4a, whereas increased the protein expression of CYCLIN D and RB. TNF-a decreased the mRNA expressions of CDK4, whereas increased the mRNA expressions of p27Kip1, CDK6, Cyclin E1/2 mRNA, the protein expression of CYCLIN D, RB and the phosphorylation of RB. The protein expression of CYCLIN D and the phosphorylation of RB were synergistically increased by IL-6 and TNF-a. The cellular viabilies were increased by IL-6 and TNF-a, which were suppressed by siRNA/CDK6.

Conclusion:

Results indicate that IL-6 and TNF-a interact with each other in regulating the cell cycle of RA-FLS, and TNF-a dominantly increases the cellular viability via CDK6.


Disclosure: K. Kaneshiro, None; K. Yoshida, None; K. Uchida, None; A. Yaekura, None; I. Okumura, None; K. Tateishi, None; Y. Terashima, None; N. Shibanuma, None; Y. Sakai, None; A. Hashiramoto, None.

To cite this abstract in AMA style:

Kaneshiro K, Yoshida K, Uchida K, Yaekura A, Okumura I, Tateishi K, Terashima Y, Shibanuma N, Sakai Y, Hashiramoto A. IL-6 and TNF-a Cooperate to Modulate Cell Cycle of RA-FLS Via Cyclin Dependent Kinase 6 [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/il-6-and-tnf-a-cooperate-to-modulate-cell-cycle-of-ra-fls-via-cyclin-dependent-kinase-6/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/il-6-and-tnf-a-cooperate-to-modulate-cell-cycle-of-ra-fls-via-cyclin-dependent-kinase-6/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology